These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 17019561

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Beneficial effect of DL-alpha-lipoic acid on cyclosporine A induced hyperlipidemic nephropathy in rats.
    Amudha G, Josephine A, Varalakshmi P.
    Mol Cell Biochem; 2007 Jul; 301(1-2):165-71. PubMed ID: 17225189
    [Abstract] [Full Text] [Related]

  • 4. Beneficial effects of sulfated polysaccharides from Sargassum wightii against mitochondrial alterations induced by Cyclosporine A in rat kidney.
    Josephine A, Amudha G, Veena CK, Preetha SP, Rajeswari A, Varalakshmi P.
    Mol Nutr Food Res; 2007 Nov; 51(11):1413-22. PubMed ID: 17918168
    [Abstract] [Full Text] [Related]

  • 5. Evaluating the effect of sulphated polysaccharides on cyclosporine a induced oxidative renal injury.
    Josephine A, Veena CK, Amudha G, Preetha SP, Varalakshmi P.
    Mol Cell Biochem; 2006 Jul; 287(1-2):101-8. PubMed ID: 16703458
    [Abstract] [Full Text] [Related]

  • 6. Oxidative and nitrosative stress mediated renal cellular damage induced by cyclosporine A: role of sulphated polysaccharides.
    Josephine A, Amudha G, Veena CK, Preetha SP, Varalakshmi P.
    Biol Pharm Bull; 2007 Jul; 30(7):1254-9. PubMed ID: 17603163
    [Abstract] [Full Text] [Related]

  • 7. Protective effect of DL-alpha-lipoic acid on cyclophosphamide induced hyperlipidemic cardiomyopathy.
    Mythili Y, Sudharsan PT, Sudhahar V, Varalakshmi P.
    Eur J Pharmacol; 2006 Aug 14; 543(1-3):92-6. PubMed ID: 16814280
    [Abstract] [Full Text] [Related]

  • 8. Selective angiotensin II type 1 receptor blockade ameliorates cyclosporine nephrotoxicity.
    Padi SS, Chopra K.
    Pharmacol Res; 2002 May 14; 45(5):413-20. PubMed ID: 12123630
    [Abstract] [Full Text] [Related]

  • 9. Resveratrol, a polyphenolic phytoalexin protects against cyclosporine-induced nephrotoxicity through nitric oxide dependent mechanism.
    Chander V, Tirkey N, Chopra K.
    Toxicology; 2005 May 15; 210(1):55-64. PubMed ID: 15804458
    [Abstract] [Full Text] [Related]

  • 10. Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus.
    Ichimaru N, Takahara S, Kokado Y, Wang JD, Hatori M, Kameoka H, Inoue T, Okuyama A.
    Atherosclerosis; 2001 Oct 15; 158(2):417-23. PubMed ID: 11583721
    [Abstract] [Full Text] [Related]

  • 11. Renoprotective effect of myricetin restrains dyslipidemia and renal mesangial cell proliferation by the suppression of sterol regulatory element binding proteins in an experimental model of diabetic nephropathy.
    Kandasamy N, Ashokkumar N.
    Eur J Pharmacol; 2014 Nov 15; 743():53-62. PubMed ID: 25240712
    [Abstract] [Full Text] [Related]

  • 12. [Study on mechanism of yangxincao capsule in regulating lipid metabolism].
    Wu FH, Liu XM, Guo SH.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Feb 15; 26(2):131-4. PubMed ID: 16548354
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sulphated polysaccharides: new insight in the prevention of cyclosporine A-induced glomerular injury.
    Josephine A, Veena CK, Amudha G, Preetha SP, Sundarapandian R, Varalakshmi P.
    Basic Clin Pharmacol Toxicol; 2007 Jul 15; 101(1):9-15. PubMed ID: 17577310
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions.
    Vaziri ND, Liang K, Azad H.
    J Pharmacol Exp Ther; 2000 Aug 15; 294(2):778-83. PubMed ID: 10900260
    [Abstract] [Full Text] [Related]

  • 19. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
    Milosavljevic D, Griglio S, Le Naour G, Chapman MJ.
    Atherosclerosis; 2001 Mar 15; 155(1):251-60. PubMed ID: 11223449
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.